Is Rhythm Pharmaceuticals, Inc. (RYTM) a Buy, Sell, or Hold?
NASDAQ : RYTM
Rhythm Pharmaceuticals, Inc.
$109.69 USD
-$0.27 (-0.25%)
- Volume
- 397.8K
- Average Volume
- 812.45K
- Market Capitalization
- $7.52B
- P/E Ratio
- -35.04
- Dividend Yield
- 0.00%
- Price Target
- $141.00
- Year High
- $122.20
- Year Low
- $74.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.17
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-22.2% DOWNSIDE
$141.00 Price Target
UPSIDE/DOWNSIDE HIGH
-29.2% DOWNSIDE
$155.00 Price Target High
UPSIDE/DOWNSIDE LOW
-12.2% DOWNSIDE
$125.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Whitney Ijem | $151 | $89.7 | 2026-06-16 06:36 AM | 68.3% |
| Stifel Nicolaus | Paul Matteis | $133 | $94.7336 | 2026-06-15 09:31 AM | 40.4% |
| Jefferies | Dennis Ding | $125 | $89.56 | 2026-03-03 05:11 PM | 39.6% |
| Stifel Nicolaus | Paul Matteis | $131 | $99.54 | 2026-02-26 12:21 PM | 31.6% |
| RBC Capital | Lisa Walter | $145 | $101.3 | 2026-02-18 04:10 PM | 43.1% |